Skip to main content

Update and Board Review in Internal Medicine: Part Two - 15.75 CME Credits

Case-based curriculum covering key knowledge in preparation for the ABIM Internal Medicine Certification Examination

Start Date: December 5, 2016
Duration: ~ 16 hours
Price: $300

Course Description

Complementary to our Part One course, the Brigham and Women's Hospital Update and Board Review in Internal Medicine Online: Part Two course comprises a review of the current practice of medicine in a wide range of specialty areas. Highly experienced Brigham Physicians/Harvard faculty, each with renowned expertise in their field of interest, deliver case-based teaching.

Update and Board Review in Internal Medicine: Part Two covers the areas of neurology, infectious disease, rheumatology, dermatology, and psychiatry. In addition, there are lectures covering a host of special topics including obesity, allergy, ENT, ophthalmology, safety and quality, geriatric medicine and contraception. Teaching is delivered through 10 hours hours of video lectures, and up to 15.75 CME points are available upon course completion.

The course incorporates interactive tools to allow self-assessment of learning and identification of knowledge gaps. It features a large question bank, consisting of knowledge check questions after each lecture, board review practice quizzes for medicine specialty areas, and a practice quiz at the end of the course.

The partner course, Update and Board Review in Internal Medicine: Part One, completes the full range of internal medicine topics relevant to the practice of internal medicine in primary care or hospital-based settings.

What You'll Learn

  • Undertake a comprehensive review of internal medicine subspecialties
  • Updated knowledge base to include recent key advances
  • Engage in extensive self-assessment activities
  • Identify and address gaps in medical knowledge
  • Complete detailed preparation for the ABIM Internal Medicine Certification Examination

Want to purchase this course for a group?

You can purchase enrollment codes for this course to distribute to your team

Purchase for a Group

Instructors

Elizabeth A. Buzney, MD

Elizabeth A. Buzney, MD Assistant Professor of Dermatology, Harvard Medical School; Associate Physician, Director, Phototherapy Center, Department of Dermatology, Brigham and Women’s Hospital

Mariana C. Castells, MD, PhD

Mariana C. Castells, MD, PhD Professor of Medicine, Harvard Medical School; Director, Drug Hypersensitivity and Desensitization Center, Director, Mastocytosis Center, Brigham and Women’s Hospital

Sonali P. Desai, MD

Sonali P. Desai, MD Assistant Professor of Medicine, Harvard Medical School; Medical Director of Quality, Department of Medicine, Medical Director of Ambulatory Patient Safety, Brigham and Women's Hospital

Florencia Halperin, MD

Florencia Halperin, MD Instructor in Medicine, Harvard Medical School; Chief of Endocrinology, Brigham and Women's Faulkner Hospital, Medical Director, Program for Weight Management

Sarah Hammond, MD

Sarah Hammond, MD Assistant Professor of Medicine, Harvard Medical School; Staff Physician, Dana-Farber Cancer Institute; Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital

Galen Henderson, MD

Galen Henderson, MD Assistant Professor of Neurology, Harvard Medical School; Director, Neurocritical Care, Department of Neurology, Brigham and Women's Hospital

Nicolas Issa, MD

Nicolas Issa, MD Assistant Professor of Medicine, Harvard Medical School; Medical Oncology, Dana-Farber Cancer Institute; Infectious Disease, Department of Medicine, Brigham and Women's Hospital

Carolyn Kloek, MD

Carolyn Kloek, MD Assistant Professor of Ophthalmology, Harvard Medical School; Clinical Director of Ophthalmology at Massachusetts Eye and Ear; Chief of the Division of Ophthalmology, Department of Surgery, Brigham and Women's Hospital

Elena Massarotti, MD

Elena Massarotti, MD Associate Professor of Medicine, Harvard Medical School; Director of Clinical Lupus Trials, Division of Rheumatology, Vice Chair of Clinical Affairs, Department of Medicine, Brigham and Women's Hospital

Scott M. McGinnis, MD

Scott M. McGinnis, MD Assistant Professor of Neurology, Harvard Medical School; Associate Neurologist, Brigham and Women's Hospital

Tracey Milligan, MD, MS. FAAN

Tracey Milligan, MD, MS. FAAN Assistant Professor of Neurology, Harvard Medical School; Vice Chair for Education, Department of Neurology, Brigham and Women's Hospital, Clinical Competency Director, Partners Neurology Residency

 Suzanne E. Salamon, MD

Suzanne E. Salamon, MD Assistant Professor of Medicine, Harvard Medical School; Associate Chief of Clinical Geriatrics, Beth Israel Deaconess Medical Center

James Stankiewicz, MD

James Stankiewicz, MD Assistant Professor of Neurology, Harvard Medical School; Clinical Director, Partners Multiple Sclerosis Center, Brigham and Women's Hospital

Dr. David Wolfe, MD

Dr. David Wolfe, MD Instructor in Psychiatry, Harvard Medical School; Director of Outpatient Services, Associate Vice Chair, Department of Psychiatry, Brigham and Women's Hospital

Sigal Yawetz, MD

Sigal Yawetz, MD Assistant Professor in Medicine, Harvard Medical School; Associate Physician, Division of Infectious Disease, Director, Program for HIV in Women and Youth, Brigham and Women's Hospital

Stacey Tutt Gray, MD

Stacey Tutt Gray, MD Assistant Professor of Otolaryngology, Program Director, Harvard Otolaryngology Residency Program, Harvard Medical School; Director, Sinus Center, Department of Otolaryngology, Massachusetts Eye and Ear

Kari P. Braaten, MD

Kari P. Braaten, MD Instructor in Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School; Associate Gynecologist, Brigham and Women's Hospital

ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

Accreditation Statement

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT

Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: Ajay K. Singh, MBBS, FCRP (UK), MBA
Role: Course Planner
Company: GlaxoSmithKline
Relationship: Consulting, Research Grant

Companies: IHS, Rockwell, Keryx, Sandoz
Relationship: Consulting

Name: Sarah Hammond, MD
Role: Course Faculty
Companies: Merck, Ansun Biopharma
Relationship: Research Support

Name: Nicolas C. Issa, MD
Role: Course Faculty
Companies: GlaxoSmithKline, Astellas
Relationship: Investigator

Name: James M. Stankiewicz, MD
Role: Course Faculty
Companies: Teva Neuroscience, EMD Serono
Relationship: Consultant, Research Support

Companies:Biogen, Genentech, Genzyme, Bayer, Novartis
Relationship: Consultant

Name: Sigal Yawetz, MD
Role: Course Faculty
Company: Gilead
Relationship: Advisory Board

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

COURSE DIRECTOR

Martina MCGrath

Dr. Martina M. McGrath, MB, BCh, FASN is an Instructor in Medicine at Harvard Medical School. She is also an Associate Physician and attending nephrologist at Brigham and Women’s Hospital.

Dr. McGrath completed her medical degree, internal medicine residency, and nephrology training in Ireland. She then completed the Brigham and Women’s Hospital/Massachusetts General Hospital Nephrology fellowship program and joined faculty at BWH and HMS in 2012.

Her subspecialty interest is in transplant nephrology, and she is an investigator in basic transplant immunology, based at the Transplantation Research Center, BWH. Her research is focused on targeting T cell costimulatory pathways in allograft rejection, and developing novel therapies to target these pathways and promote the development of regulatory T cells and allograft tolerance. She also is active in the area of medical education, serving as course director for the combined BWH/HMS Update in Internal Medicine series of courses. View Dr. McGrath's profile.



COURSE OUTLINE

Update and Board Review in Internal Medicine: Part Two is structured as follows. There are one to four lectures under each bulleted subsection, and subsections end with board review practice questions. Learners must pass the final posttest with a score of 75% or higher to claim their CME certificate:

Module 1: Neurology
  • Update in Neurology
  • Selected Topics in Ischemic Stroke
  • Multiple Sclerosis
Neurology: Board Review Practice Quiz

Module 2: Infectious Disease
  • Update in Infectious Diseases
  • Vaccines in Adults
  • Infectious Disease in Immunocompromised Hosts
  • Sexually Transmitted Infections
Infectious Disease: Board Review Practice Quiz

Module 3: Rheumatology
  • Rheumatology Review
Rheumatology: Board Review Practice Quiz

Module 4: Dermatology
  • Dermatology Case Reviews
Dermatology: Board Review Practice Quiz

Module 5: Special Topics
  • Obesity
  • Allergy
  • Ear, Nose, and Throat
  • Ophthalmology
  • Safety and Quality in Ambulatory Care
  • Dementia
  • Geriatric Medicine
  • Contraception
Special Topics: Board Review Practice Quiz

Module 6: Psychiatry
  • Selected Topics in Psychiatry
CME Certificate
  • Posttest
  • Course Evaluation

FREQUENTLY ASKED QUESTIONS

How long will this course take?

This course should take approximately 16 hours to complete. You do not need to complete it all at once. You may come back as often as you would like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox or Safari, or with Internet Explorer version 9 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year, please see our course catalogue for upcoming events

MORE TO EXPLORE

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year, please see our course catalog for upcoming events.

Enroll